Key Record Dates
ClinicalTrials.gov Identifier: | NCT01419197 |
---|---|
Brief Title: | A Study of Trastuzumab Emtansine in Comparison With Treatment of Physician's Choice in Participants With HER2-positive Breast Cancer Who Have Received at Least Two Prior Regimens of HER2-directed Therapy (TH3RESA) |
First Submitted : | August 16, 2011 |
First Submitted that Met QC Criteria : | August 16, 2011 |
First Posted : | August 18, 2011 (Estimate) |
Results First Submitted : | February 7, 2014 |
Results First Submitted that Met QC Criteria : | April 3, 2014 |
Results First Posted : | May 5, 2014 (Estimate) |
Last Update Submitted that Met QC Criteria : | August 17, 2016 |
Last Update Posted : | October 12, 2016 (Estimate) |